Skip to main content
XOMA Royalty Corp logo

XOMA Royalty Corp — Investor Relations & Filings

Ticker · XOMA ISIN · US98419J3059 US Financial and insurance activities
Filings indexed 1,095 across all filing types
Latest filing 2026-05-26 Merger & Acquisition
Country US United States of America
Listing US XOMA

About XOMA Royalty Corp

https://xoma.com/

XOMA Royalty Corp. is a biotech royalty aggregator that acquires economic rights to potential future milestone and royalty payments. The company's portfolio consists of assets associated with pre-commercial clinical candidates being developed by various pharmaceutical and biotech partners. In exchange for these economic rights, XOMA provides its partners with non-dilutive, non-recourse capital to fund their internal drug development programs. This portfolio-based strategy, encompassing over 120 assets, is designed to diversify risk away from single-asset clinical outcomes. XOMA focuses on managing these royalty assets rather than direct drug development.

Recent filings

Filing Released Lang Actions
425
Merger & Acquisition
2026-05-26 English
8-K
Regulatory Filings
2026-05-22 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-18 English
8-K
Regulatory Filings
2026-05-18 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-12 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.